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ABSTRACT
Objective: The aim of this study was to explore and
understand women’s experience with cervical cancer
screening and with the referral pathways for abnormal
Papanicolau (Pap) smears.
Design and setting: Focus group discussions were
conducted with first time colposcopy clinic attendees
at a tertiary hospital colposcopy clinic in Cape Town,
South Africa during November 2014. A thematic
analysis was conducted to identify key themes. Initial
coding categories were drawn from the interview guide.
Participants: 27 women participated in 4 focus group
discussions.
Results: Participants mean age was 34 years, most
did not complete secondary level education and were
unemployed. Negative community opinions relating to
Pap smears and colposcopy referral might deter
women from seeking treatment. Having a
gynaecological symptom was the most commonly
cited reason for having a Pap smear. Fear of having a
HIV test performed at the same time as Pap smear and
low encouragement from peers, were factors identified
as potential access barriers. Participants commented
on insufficient or lack of information from primary
providers on referral to the colposcopy clinic and
concerns and apprehension during waiting periods
between receiving results and the colposcopy
appointment were discussed.
Conclusions: There is a strong and urgent need to
improve current knowledge about cervical cancer and
Pap smears and the necessity and benefits of timely
access to screening programmes, results and
treatment. Strategies such as community health
education programmes and mass media interventions
could be employed to disseminate cervical cancer
information and address negative community
perceptions. Better training and support mechanisms
to equip healthcare providers with the skills to convey
cervical cancer information to women are needed. The
use of short message service (SMS) to deliver Pap
smear results and provide patients with more
information should be considered to improve waiting
times for results and alleviate apprehension during
waiting periods.
INTRODUCTION
Cervical cancer is the fourth cause of death
in women worldwide.1 In low income and
middle income countries (LMIC) it is a sig-
niﬁcant public health threat exacerbated by
limited access to health services and human
and ﬁnancial resources, high rates of poverty
and lack of awareness.2 These factors in com-
bination with poor medical infrastructure
hinder the facilitation of early detection and
treatment. In South Africa cervical cancer is
the second most common cancer among
women and the most common type of
cancer among women between the ages 15
to 44 years.3 Moreover, it is the leading cause
of cancer mortality among women.3
The successful implementation of cervical
screening programmes with well-functioning
call and recall systems has resulted in a
decline in cervical cancer incidence and
mortality in high-income countries.4 5 In
contrast, cervical cancer remains a problem
in LMIC, mostly because of ineffective or
Strengths and limitations of this study
▪ This study adds to a limited number of empirical
studies seeking to explore the views of women
about the cervical screening and colposcopy
referral process.
▪ This study builds on previous empirical research,
which found that women in South Africa may
have limited knowledge of cervical cancer and
Pap smears.
▪ This study provides greater understanding of
women’s experiences with cervical cancer
screening processes.
▪ This study was conducted at one colposcopy
clinic in the Western Cape Province of South
Africa and this limits its generalisability.
▪ A limitation of this study is that only women
who have accessed healthcare were included.
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absent screening programmes.5 6 Limited knowledge
about cervical cancer and screening programmes have
been reported among women in South Africa and other
LMICs.7–11 Furthermore, studies have indicated that a
lack of adequate knowledge about cervical cancer and
screening programmes can detrimentally inﬂuence
women’s likelihood of accessing such programmes.9 12
A Papanicolau (Pap) smear can screen for precancer-
ous abnormalities, and if clients with abnormalities are
further investigated and treated, cervical cancer can be
prevented. Further investigation usually includes a colpos-
copy assessment. A key challenge in the implementation
of Pap smear screening programmes in LMIC is poor col-
poscopy attendance and loss to follow-up of women with
abnormal Pap smears.6 13 In 2000 South Africa intro-
duced its ﬁrst cervical cancer screening policy. According
to the policy women aged 30 years and older attending
public sector services are entitled to three free Pap
smears in their lifetime.14 Pap smear screening services
are available at the primary healthcare facilities through-
out the country. National screening coverage has
increased from 18% in 2003 to 55% in 2014.15
A recent study conducted in three provinces in South
Africa highlighted the challenges in getting women with
abnormal Pap smears to attend colposcopy appoint-
ments.16 In this study, although appointments were
made for all women with a high-grade squamous intrae-
pithelial lesion, only 50% of the women attended the
colposcopy clinic. This poor attendance rate occurred
despite efforts to improve interfacility linkages and estab-
lish paper-based feedback systems. This study did
however not explore reasons for poor attendance.
Numerous studies have emphasised the need for
regular screening and for improving access to informa-
tion about cervical cancer. However, few studies have
been conducted in LMIC where additional challenges
such as barriers to access and knowledge may exist.
Moreover, there is a deﬁcit of empirical research seeking
to explore the views of women about the cervical screen-
ing and colposcopy referral process. This study therefore
sought to examine women’s experiences with cervical
cancer screening and to better understand the referral
pathways for women with abnormal Pap smears.
METHODS
Study design and sample
The study ﬁndings reported in this article form part of a
larger study on the feasibility of mobile health interven-
tions to improve the management of women with abnor-
mal Pap smears. As part of the study focus group
discussions were conducted with ﬁrst time colposcopy
clinic attendees at a tertiary hospital colposcopy clinic in
the Western Cape Province, South Africa during
November 2014.
In our study area women are typically asked to return
to the primary healthcare clinic within 6–8 weeks for
their Pap smear result, which is the average waiting
period for the area. Women with abnormal Pap smears
that is, either a high-grade squamous intraepithelia
lesion or a second low-grade intraepithelial lesion are
referred for further assessment to a colposcopy clinic
based at the referral tertiary hospital. Colposcopy
appointments are made by the primary healthcare pro-
vider at the time that clients return for their Pap smear
result. Colposcopy services are fee-free and typically
women wait between 1 and 8 months for a colposcopy
appointment.
Women who met the study eligibility criteria (referred
to the colposcopy clinic from a primary health facility;
ability to understand and converse in English, Afrikaans
or Xhosa and willing to provide informed consent) were
approached by the research team to ascertain interest to
participate. Twenty-seven women were approached and
all were eligible and consented to participate in four
focus group discussions conducted in a private room.
Informed consent was obtained and a brief sociodemo-
graphic survey was administered (age; employment; edu-
cation; type of housing; home language; mobile phone
ownership and usage). Group discussions lasted between
90 and 120 min. Participants received incentives worth
ZAR100 for taking part in the study and refreshments
during the focus group discussions. Additional cervical
cancer or colposcopy information in the form of pamph-
lets was made available after the focus group discussions.
Two female researchers trained in qualitative methods
conducted the discussions in English, with Afrikaans
and isiXhosa translation provided where necessary. The
following broad themes were explored: cervical cancer
and Pap smear knowledge; means of obtaining Pap
smear results; referral pathway to the colposcopy clinic;
expectations and knowledge about the colposcopy
appointment; views and opinions about the use of short
message service (SMS) to convey results and appoint-
ment reminders. Focus group discussions were digitally
recorded and ﬁeld notes were also made.
Data analysis
All digital recordings and ﬁeld notes were translated
into English and transcribed. Transcripts were reviewed
by JM and data collection stopped once data saturation
was achieved. Transcripts were not returned to partici-
pants for comment. Data were entered and coded into
QSR Nvivo V.10 (a qualitative computer software
package). Conventional thematic analysis was conducted
to identify key themes. Initial coding categories for ana-
lysing data were drawn from the interview guide. MM
and JM read the transcripts and developed initial coding
categories (see online supplementary ﬁle 1). MM coded
the data and JM reviewed codes and identiﬁed sub-
themes. Once all the text segments had been given basic
codes, the codes were categorised and grouped into
similar themes. No additional themes emerged from this
process. Selected participant quotations were chosen to
illustrate both themes and ﬁndings. Each quotation was
identiﬁed using a unique participant ID. Data presented
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was consistent with study ﬁndings and all major themes
were clearly presented and discussed, while minor
themes are described in the ﬁndings.
RESULTS
Participant profile
Sociodemographic characteristics were collected from all
27 women who participated in the focus group discus-
sions. The mean age was 34 years (range 18–49). A major-
ity of participants (85%) did not complete secondary level
education and 48% were unemployed. Participants were
mostly Xhosa speakers (71%) and 26% spoke Afrikaans.
Majority of participants identiﬁed themselves as black
African (74%) followed by Cape Coloured (26%). Most
participants reportedly lived in houses (59%), 19% lived
in informal structures (shacks), 15% in cottages/sheds
behind another house and 7% lived in ﬂats.
Community views on Pap smears and cervical cancer
When asked whether cervical cancer and Pap smears in
particular were topics that were discussed among peers,
most women admitted to rarely hearing others talking
about it in their respective communities. Negative com-
munity opinions relating to Pap smears and colposcopy
referral in particular, were discussed by some as factors
which deter women from seeking screening and further
assessment.
When you have gone for a Pap smear and maybe you tell
others about, they will tell you that: ‘Oh! When you go
there they will ﬁnd this and that, it’s better not to go at
all.’ It is worse when you tell them that you are referred
to [colposcopy clinic]. Then they say: ‘you see, you
should not have gone there. Now you must go to [colpos-
copy clinic] and they are now going to tell you that they
must burn something underneath there. Maybe they will
tell you that something is growing in your womb and
they must take it out.’ People in the community say you
must leave this Pap smear ‘cause it make you very
worried. (FGD21)
Nobody accepts that she has cervical cancer; it is like
being HIV positive. It’s something that is not acceptable in
the community. You tend to keep it to yourself because if
you tell someone about it she will going around making a
laughing stock in the streets about that. (FGD22)
Some women commented on cervical cancer being
less stigmatised in their respective communities than it
had been previously. However, others felt it was still
heavily stigmatised and many discussed the negative asso-
ciation of being seen at the clinic and being assumed by
the community to be HIV positive.
Others are afraid of stigma of being seen at the clinic,
they think that if you see them there you are going to
talk about her in the community. Another thing once
they see you there they think that everyone there is HIV
positive. If you tell someone that you are going or you
have done a Pap smear immediately they say you are
[HIV] positive. (FGD31)
There is a perception in the community that if you do a
Pap smear you are HIV positive. So people tend to shy
away from doing a Pap smear. Even if you do it while you
are pregnant you do not tell anyone because there is that
perception. (FGD41)
Reasons for having a Pap smear
Having a gynaecological symptom was the main reason
reported for having a Pap smear. However, the symptoms
that prompted women to have a Pap smear performed
varied greatly and included abdominal pain, heavy
periods, spotting between periods, pain on urination and
vaginal discharge and itching. Other participants were
encouraged by health professionals to have a Pap smear
performed and a few were encouraged by their peers.
Many referred to wanting their womb cleaned in order
to conceive. Having a Pap smear was frequently seen as
diagnostic rather than preventative measure of cancer.
Moreover, some women thought that the cleaning of the
womb procedure enabled health providers to identify
whether it was damaged and subsequently remove it.
People say that if you do a Pap smear they will tell you
that you have cancer or ﬁnd out that your womb has a
green discolouration and that will lead to them taking
out your womb. (FGD23)
They [health providers] clean the uterus and if they ﬁnd
out that it is damaged, they take it out. (FGD11)
Reasons for not having a Pap smear
Some participants mentioned fear of having a HIV test
performed at the same time as a Pap smear is a poten-
tial barrier to women accessing screening procedures.
The reason they [women in community] are scared of
having a pap smear is because they are worried that they
will also be checked for HIV. (FGD32)
As discussed under the previous heading ‘community
views’, low encouragement by their peers also deterred
women from having a Pap smear.
Healthcare provider interaction and communication
(receiving results and referral to colposcopy clinic)
Most women were asked to return to the clinic within 6–
8 weeks following their Pap smear to discuss their
results, while some were notiﬁed by post to return to the
clinic. Participants, who were HIV positive and already
attending the clinic regularly for treatment, incorpo-
rated getting their results into these visits, while some
reported challenges in receiving their results;
…Sometimes you do not get your letters. My letter was
delivered two doors from my house and those people
brought it to me. [Neighbours had also opened letter]
(FGD13)
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There’s a lot of airtime that you are using [trying to
obtain Pap smear results], because they put on hold, it’s
expensive. (FGD34)
The main concern appeared to relate to anxieties
during the waiting period and uncertainty about the
safety of the procedure. Many participants commented
on the lack of information received from the primary
provider on referral to the colposcopy clinic.
They [primary referring clinic] did not say anything. I
was given a letter and a date to come here [colposcopy
clinic]. (FGD11)
I’m here today and I really do not know why I’m here [at
colposcopy clinic]. They [primary referring clinic] never
explained to me what the results say. They [primary
referring clinic] just told me that they have made an
appointment for me here [colposcopy clinic] but I do
not know for what. (FGD21)
Some women, who had their Pap smear results
explained, admitted to not understand the explanation.
However, they did not ask for clariﬁcation.
No, I did not [ask for further clariﬁcation/explanation].
I was just given the letter to come here [colposcopy
clinic]. Sometimes when they are telling you, you are also
shocked and worried so you do hear some of the things
they tell you. (FGD23)
No, [I did not ask for further clariﬁcation/explanation] I
didn’t want to worry myself. (FGD35)
Differences were reported in terms of the quality of
information received depending on the type of primary
referring clinic. Women who were referred from anti-
retroviral (ARV) clinics reported receiving counselling
and information about their Pap smear results whereas
those referred from non-ARV facilities reported receiv-
ing little or no information. Participants framed this in
terms of ARV facilities generally having better resources,
in terms of staff and infrastructure.
Waiting periods between receiving results and the col-
poscopy appointment varied greatly, with some women
waiting a month and others waiting up to 6 months.
Many raised concerns and apprehension during the
long waiting period between obtaining results and the
colposcopy appointment. These trepidations were com-
pounded by not knowing how to interpret the results or
what to expect at the colposcopy appointment. Many
informants talked about expectation that ‘something’ in
their ‘womb’ will be burned and most expressed con-
cerns about the colposcopy procedure.
I’m expecting anything could be said. Being a woman we
are prone to have many things. (FGD15)
For me what is worrying if the fact that they [primary
referring clinic] don’t tell you your results. They tell you
that you must go to [colposcopy clinic] because there is
something wrong. Now you are worried for the more
than one and half months, wondering what is actually
wrong with you. I would feel better if they did explain to
me what the results of my Pap smear are saying and be
prepared for what I’m going to do [at colposcopy clinic].
It’s big problem for me because you are sitting with this
letter which you don’t know what it says. (FGD21)
… I just became depressed and very worried because I
had told myself that this is the end. I don’t even function
well at work and I’ve since lost a lot of weight. It has
been a very hard time for me. (FGD34)
DISCUSSION
The use of qualitative methods in formative research is
gaining increasing acceptance as a mode of scientiﬁc
inquiry and may be an essential foundation for success-
ful interventions. Women’s voices become more audible
through qualitative research, which emphasises the
importance of providing a safe space for women to
express their unique experiences while gaining support
from other women with a common cultural
background.17 18
Research from LMICs has identiﬁed a variety of
factors which inﬂuence women’s screening practices for
cervical cancer, including: ﬁnancial implications; accessi-
bility; waiting periods and the quality of services;19 20 dis-
comfort associated with the procedure; and mistrust of
the medical system;7 8 20 21 the inﬂuence of husband
and/or family and the use of traditional medicine.22
These potential barriers to routine screening services
were explored during the discussions but were insigniﬁ-
cant for our study participants.
Our ﬁndings build on previous empirical research,
which found that women in South Africa and more
broadly in LMICs may have limited knowledge of cer-
vical cancer and Pap smears.7–11 While all participants
used words such as Pap smear and colposcopy, many
were not able to distinguish the differences between the
two procedures. Studies conducted in LMICs revealed
that a lack of knowledge on the topic can severely deter
women’s likelihood of accessing cervical screening pro-
grammes.9 12 Although the availability and accessibility
of screening services are vital, this alone does not guar-
antee uptake. A study conducted in a rural district of
KwaZulu-Natal, found although 49% of the women who
participated in the study knew about Pap smears, more
than half did not undertake the test—most commonly
because of a perceived fear of the procedure.21 Study
participants frequently referred to having their ‘womb
cleaned’. This ﬁnding is consistent with other studies
that South African women often construct cervical
cancer in non-medical terms and rarely use the term
cervix in reference to cervical cancer.23
Our ﬁndings echo previous research that identiﬁed a
general perception that the Pap smears are frequently
seen as diagnostic of cervical cancer, rather than a
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preventative or intervention measure.23 24 However, this
ﬁnding might be inﬂuenced by the fact that our study only
included women with abnormal Pap smear results. The
reluctance many of the study participants spoke of to have
a Pap smear for fear that they would be diagnosed with
cervical cancer and a general consensus that it is better
not to know than know you have cancer also needs to be
addressed. A strong and urgent need therefore exists to
improve women’s knowledge about cervical cancer and
the necessity and beneﬁts of timely access to screening.
Our study speaks of deep-rooted misconceptions and
stigma about cervical cancer at a community level. The
use of community outreach workers to promote cervical
cancer knowledge and to improve screening uptake has
yielded positive results in some settings.25–27 Previous
well-organised cervical screening programmes have failed
to be effective without the incorporation of community
health education programmes.6 28 Similarly, planned
mass media interventions (including radio, television,
newspapers, magazines, leaﬂets, posters and pamphlets)
to improve cancer screening programmes had a positive
effect on healthcare usage.29 The use of such strategies
to disseminate cervical cancer information at grass root
level using locally understood messages could therefore
facilitate greater, more accurate understanding.
Healthcare providers appear to be providing insufﬁ-
cient or inappropriate information at the time of refer-
ral, causing unnecessary concern and anxiety in the
period leading to the colposcopy appointment. Previous
studies have reported inadequacies in training of health
professionals and the management of patients with cer-
vical cancer.9 30 31 Healthcare providers play a pivotal
role in improving quality of care and improving knowl-
edge and are in a unique position to potentially modify
structural and process factors that impact health out-
comes.32 33 Informed decision-making (IDM), is said to
occur when an individual understands the disease being
addressed and comprehends what the clinical manage-
ment entails; including the beneﬁts, risks, limitations
and alternatives. The individual has also considered
their unique preferences and believe they have partici-
pated in the decision-making process.34 The usage of
IDM strategies by providers to enhance patient knowl-
edge, beliefs and risk perceptions in cancer screening
interventions have proven successful in some settings,
but insufﬁcient research has been carried out to assess
its effectiveness in LMIC settings.35 36 Better training
and support mechanisms are required to equip staff with
the necessary skills to convey information in a manner
that can be better understood by the populations they
serve. The potential beneﬁts of employing IDM strat-
egies in a South African setting should be investigated.
A growing body of research have proven the effective-
ness of SMS/text messages in support of behavioural
change and disease management.37 38 Such interven-
tions could enhance the current standard of care with
information provided through mobile phones could
help improve health outcomes and processes.38 The use
of SMS to deliver Pap smear results and provide patients
with more information should be considered to improve
waiting times for results and alleviate apprehension
during waiting periods.
Owing to the explorative methodology employed in
this study, ﬁndings are descriptive in nature. Although
only 27 women participated in four focus group discus-
sions, we believe that saturation was reached as no new
themes emerged. As is usual in focus group discussions,
some women were more willing to contribute to the dis-
cussions than others. We acknowledge that more vocal
participants in the group may have inﬂuenced less forth-
coming participants’ responses. However, probing tech-
niques were employed to encourage quieter participants
to actively contribute to the discussions. A major limita-
tion of this study is that only women who have accessed
healthcare were included.
This study was designed to examine women’s experi-
ences with cervical cancer screening and the referral
pathways for women with abnormal Pap smears.
Signiﬁcant concerns were identiﬁed among the women
we interviewed, despite their ability to access cervical
screening services. Women who do not access cervical
screening programmes are likely to experience add-
itional barriers which were not explored in this study.
Awareness of cervical cancer and factors inﬂuencing
women’s willingness to undergo screening procedures
among women that have not accessed care needs to be
explored. However, our ﬁndings do provide greater
understanding of women’s knowledge of cervical cancer
and experiences with screening and referral processes.
CONCLUSION
This study highlights signiﬁcant gaps in women’s knowl-
edge about cervical cancer and Pap smears and, import-
antly, also the further management in case an
abnormality is identiﬁed which can have a negative effect
on healthcare usage. A strong and urgent need therefore
exists to improve current knowledge on the topic and the
necessity and beneﬁts of timely access to screening pro-
grammes. Strategies such as community health education
programmes and mass media interventions should be
employed to disseminate cervical cancer information
and address negative community perceptions. Better
training and support mechanisms to equip healthcare
providers with the skills to convey cervical cancer infor-
mation to women are needed. The use of IDM strategies
to enhance patient knowledge and participation in the
decision-making process should be investigated.
Strategies should aim to better inform women about cer-
vical cancer, the beneﬁt of early screening and what to
expect if referred to a Colposcopy clinic thus potentially
alleviating any unnecessary stress and concern women
have about cervical screening and treatment pro-
grammes. The use of SMS to deliver Pap smear results
and provide patients with more information should be
considered to improve waiting times for results and allevi-
ate apprehension during waiting periods.
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